Biotechnology
The Biotechnology industry has a total of 599 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.29 billion.
Market Cap
1.12T
Revenue
105.29B
Profits
-41.55B
PE Ratio
n/a
Profit Margin
-39.46%
Dividend Yield
0.04%
599 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.15B | -0.80% | 73,559 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.06B | -0.40% | 91,237 | 14.25B |
| 3 | ARGX | argenx SE | 49.27B | 0.91% | 17,041 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 49.04B | 1.19% | 68,211 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.56B | -2.12% | 8,645 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.44B | -1.22% | 106,601 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.48B | -3.30% | 126,124 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.54B | 0.46% | 131,400 | - |
| 9 | RPRX | Royalty Pharma plc | 23.01B | -0.85% | 113,729 | 2.35B |
| 10 | GMAB | Genmab A/S | 21.63B | -3.65% | 339,719 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.79B | -0.07% | 107,721 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 16.46B | -0.63% | 192,224 | 20.33M |
| 13 | MRNA | Moderna, Inc. | 15.39B | -2.92% | 1,333,582 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.71B | -2.04% | 324,243 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.33B | -2.07% | 130,898 | - |
| 16 | ASND | Ascendis Pharma A/S | 13.17B | -1.24% | 12,964 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.66B | -0.93% | 44,435 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.25B | 0.60% | 143,032 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -0.08% | 3,159 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | -0.03% | 42,725 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.69B | 0.26% | 271,960 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.63B | -1.30% | 56,894 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.23B | -1.48% | 40,601 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.80B | 2.39% | 348,118 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.26B | 2.18% | 223,510 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.88B | -0.44% | 30,523 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.45B | -1.52% | 21,614 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 8.38B | 0.09% | 82,360 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 8.31B | 0.32% | 18,808 | 7.46M |
| 30 | KRYS | Krystal Biotech, Inc. | 8.29B | -1.98% | 15,257 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.86B | -0.48% | 49,835 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.36B | -1.21% | 169,163 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.35B | -2.78% | 39,576 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.19B | -2.60% | 26,666 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.18B | -0.38% | 29,008 | 1.78B |
| 36 | KYMR | Kymera Therapeutics, Inc. | 5.98B | -0.64% | 8,003 | 43.74M |
| 37 | BLTE | Belite Bio, Inc | 5.79B | 0.42% | 19,144 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 5.74B | -0.11% | 98,961 | - |
| 39 | GPCR | Structure Therapeutics Inc. | 5.68B | -2.57% | 109,184 | - |
| 40 | APGE | Apogee Therapeutics, Inc. | 5.62B | 0.95% | 14,288 | - |
| 41 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.56B | -2.15% | 10,721 | 1.54M |
| 42 | IMVT | Immunovant, Inc. | 5.34B | -3.60% | 38,270 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.30B | -0.61% | 21,284 | 209.22M |
| 44 | CELC | Celcuity Inc. | 5.28B | -0.33% | 41,667 | - |
| 45 | CRSP | CRISPR Therapeutics AG | 5.24B | -3.32% | 210,365 | 38.34M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 4.69B | 0.04% | 24,773 | 471.79M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.60B | -1.08% | 75,438 | - |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.53B | -0.30% | 117,819 | 1.05B |
| 49 | TGTX | TG Therapeutics, Inc. | 4.45B | 3.15% | 366,910 | 531.90M |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.44B | -0.17% | 318,486 | 598.70M |
| 51 | CGON | CG Oncology, Inc. | 4.42B | -1.32% | 30,327 | 2.17M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.23B | -2.68% | 133,187 | 488.56M |
| 53 | LEGN | Legend Biotech Corporation | 4.20B | -2.28% | 158,811 | 909.05M |
| 54 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | -0.65% | 188,709 | - |
| 55 | ACLX | Arcellx, Inc. | 4.00B | -0.91% | 25,677 | 35.90M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.84B | -0.78% | 26,427 | 251.23M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.81B | -2.13% | 115,483 | 741.17M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.79B | -2.33% | 588,801 | - |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 3.60B | -0.53% | 61,971 | 35.24M |
| 60 | LQDA | Liquidia Corporation | 3.49B | 0.20% | 293,825 | 69.22M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.34B | -2.81% | 40,786 | - |
| 62 | BEAM | Beam Therapeutics Inc. | 3.34B | -4.43% | 204,145 | 55.70M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.28B | 1.65% | 135,794 | 15.00M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.27B | -0.04% | 75,003 | 317.93M |
| 65 | IBRX | ImmunityBio, Inc. | 3.26B | 9.60% | 12,610,024 | 82.56M |
| 66 | VRDN | Viridian Therapeutics, Inc. | 3.20B | -0.68% | 77,730 | 70.79M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.19B | -0.60% | 67,205 | 7.50M |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | -0.70% | 10,375 | 366.10M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 3.11B | -4.13% | 121,298 | 214.83M |
| 70 | ALMS | Alumis Inc. | 3.07B | 1.07% | 404,593 | 22.12M |
| 71 | RCUS | Arcus Biosciences, Inc. | 2.94B | -3.30% | 46,744 | 240.00M |
| 72 | DNLI | Denali Therapeutics Inc. | 2.87B | 0.49% | 98,670 | - |
| 73 | EWTX | Edgewise Therapeutics, Inc. | 2.87B | -3.90% | 42,310 | - |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | -1.51% | 52,153 | 578.20M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.78B | -3.27% | 84,730 | - |
| 76 | ADPT | Adaptive Biotechnologies Corporation | 2.75B | - | 50,361 | 252.75M |
| 77 | IRON | Disc Medicine, Inc. | 2.73B | -6.33% | 386,490 | - |
| 78 | MLYS | Mineralys Therapeutics, Inc. | 2.61B | -1.12% | 89,336 | - |
| 79 | OCUL | Ocular Therapeutix, Inc. | 2.61B | 10.84% | 12,392,159 | 55.78M |
| 80 | SYRE | Spyre Therapeutics, Inc. | 2.61B | 1.49% | 43,419 | - |
| 81 | APLS | Apellis Pharmaceuticals, Inc. | 2.57B | -0.20% | 124,911 | 1.02B |
| 82 | WVE | Wave Life Sciences Ltd. | 2.56B | -3.58% | 436,029 | 109.23M |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.53B | -2.23% | 12,915 | 664.23M |
| 84 | AAPG | Ascentage Pharma Group International | 2.52B | - | 161 | 54.52M |
| 85 | TVTX | Travere Therapeutics, Inc. | 2.48B | -4.08% | 233,769 | 435.83M |
| 86 | ERAS | Erasca, Inc. | 2.46B | 4.45% | 1,584,988 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.44B | -3.30% | 4,269,221 | 43.69M |
| 88 | MESO | Mesoblast Limited | 2.33B | 0.74% | 11,304 | 17.20M |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | -4.61% | 322,272 | 2.41B |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -1.99% | 66,185 | 630.60M |
| 91 | SLNO | Soleno Therapeutics, Inc. | 2.27B | -0.42% | 76,284 | 98.68M |
| 92 | IMNM | Immunome, Inc. | 2.26B | -1.25% | 101,073 | 9.68M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.24B | -0.94% | 49,526 | - |
| 94 | GLPG | Galapagos NV | 2.24B | 0.53% | 18,391 | 336.64M |
| 95 | NUVB | Nuvation Bio Inc. | 2.11B | -2.61% | 515,406 | 26.75M |
| 96 | ZLAB | Zai Lab Limited | 2.09B | -4.23% | 90,881 | 441.63M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | 0.29% | 115,366 | 825.94M |
| 98 | MBX | MBX Biosciences, Inc. | 2.00B | 3.48% | 137,840 | - |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -1.08% | 65,371 | 265.81M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.97B | -0.32% | 6,549 | 2.50M |
| 101 | DNTH | Dianthus Therapeutics, Inc. | 1.94B | -2.11% | 39,644 | 3.08M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.94B | 0.53% | 162,005 | 83.69M |
| 103 | GLUE | Monte Rosa Therapeutics, Inc. | 1.91B | 0.37% | 30,619 | 181.54M |
| 104 | VCEL | Vericel Corporation | 1.91B | 1.15% | 45,147 | 258.72M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -0.68% | 58,527 | 111.30M |
| 106 | ZYME | Zymeworks Inc. | 1.82B | -1.34% | 523,776 | 134.48M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.82B | -1.18% | 6,639 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.77B | 0.10% | 42,787 | 205.63M |
| 109 | KOD | Kodiak Sciences Inc. | 1.75B | -1.78% | 20,703 | - |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.73B | -1.27% | 10,579 | 2.60M |
| 111 | UPB | Upstream Bio, Inc. | 1.73B | -1.15% | 44,934 | 2.80M |
| 112 | MNKD | MannKind Corporation | 1.72B | - | 272,846 | 313.79M |
| 113 | NBY | NovaBay Pharmaceuticals, Inc. | 1.71B | 6.83% | 389,719 | 10.30M |
| 114 | ARDX | Ardelyx, Inc. | 1.68B | 0.44% | 810,297 | 398.23M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | -0.68% | 34,893 | 44.79M |
| 116 | PHVS | Pharvaris N.V. | 1.66B | -0.31% | 10,562 | - |
| 117 | TNGX | Tango Therapeutics, Inc. | 1.64B | -1.45% | 333,667 | 66.50M |
| 118 | IMCR | Immunocore Holdings plc | 1.64B | -1.81% | 5,803 | 379.59M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.56B | 0.36% | 54,853 | - |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.54B | -0.41% | 35,400 | - |
| 121 | BHVN | Biohaven Ltd. | 1.52B | -2.31% | 353,119 | - |
| 122 | PGEN | Precigen, Inc. | 1.51B | -3.17% | 188,989 | 6.31M |
| 123 | FTRE | Fortrea Holdings Inc. | 1.51B | -2.68% | 54,363 | 2.76B |
| 124 | ELVN | Enliven Therapeutics, Inc. | 1.47B | -4.76% | 107,024 | - |
| 125 | INVA | Innoviva, Inc. | 1.45B | -1.57% | 6,479 | 388.52M |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.44B | -1.92% | 11,981 | - |
| 127 | SVRA | Savara Inc. | 1.42B | -2.17% | 91,842 | - |
| 128 | EYPT | EyePoint, Inc. | 1.40B | 6.60% | 206,986 | 42.34M |
| 129 | RLAY | Relay Therapeutics, Inc. | 1.38B | -1.61% | 50,523 | 8.36M |
| 130 | OCS | Oculis Holding AG | 1.37B | 0.38% | 57,237 | 992.00K |
| 131 | QURE | uniQure N.V. | 1.36B | -2.42% | 90,471 | 15.75M |
| 132 | ANAB | AnaptysBio, Inc. | 1.35B | -2.92% | 56,093 | 169.47M |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | -2.38% | 117,927 | 6.31M |
| 134 | NTLA | Intellia Therapeutics, Inc. | 1.35B | -3.24% | 853,758 | 57.53M |
| 135 | ATAI | AtaiBeckley Inc. | 1.34B | -0.54% | 329,130 | 3.02M |
| 136 | IMTX | Immatics N.V. | 1.34B | 1.32% | 15,014 | 99.45M |
| 137 | NVAX | Novavax, Inc. | 1.30B | -2.38% | 777,163 | 1.06B |
| 138 | RAPP | Rapport Therapeutics, Inc. | 1.26B | -3.30% | 10,178 | - |
| 139 | PHAR | Pharming Group N.V. | 1.26B | -2.03% | 2,772 | 362.27M |
| 140 | SANA | Sana Biotechnology, Inc. | 1.25B | -0.74% | 274,183 | - |
| 141 | CAPR | Capricor Therapeutics, Inc. | 1.25B | -2.78% | 79,730 | 11.13M |
| 142 | XERS | Xeris Biopharma Holdings, Inc. | 1.25B | -0.92% | 191,107 | 266.14M |
| 143 | PVLA | Palvella Therapeutics, Inc. | 1.25B | -0.09% | 1,536 | - |
| 144 | ABCL | AbCellera Biologics Inc. | 1.23B | -3.96% | 482,037 | 35.33M |
| 145 | SEPN | Septerna, Inc. | 1.20B | 0.64% | 10,397 | 22.05M |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.17B | -5.49% | 586,675 | - |
| 147 | PHAT | Phathom Pharmaceuticals, Inc. | 1.13B | -4.43% | 65,147 | 147.19M |
| 148 | IVA | Inventiva S.A. | 1.13B | 2.17% | 81,302 | 19.93M |
| 149 | SPRY | ARS Pharmaceuticals, Inc. | 1.13B | -3.39% | 58,145 | 142.77M |
| 150 | DAWN | Day One Biopharmaceuticals, Inc. | 1.12B | 2.05% | 1,139,612 | 133.67M |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.11B | -7.93% | 181,867 | 15.00M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -0.17% | 4,037 | 1.40M |
| 153 | ORIC | ORIC Pharmaceuticals, Inc. | 1.10B | 0.44% | 129,194 | - |
| 154 | AKTS | Aktis Oncology, Inc. | 1.07B | -2.38% | 33,532 | 5.56M |
| 155 | TBPH | Theravance Biopharma, Inc. | 1.05B | 0.10% | 13,510 | 80.33M |
| 156 | CMPX | Compass Therapeutics, Inc. | 1.03B | -3.81% | 452,650 | 850.00K |
| 157 | NBTX | Nanobiotix S.A. | 1.03B | 3.20% | 8,145 | 11.93M |
| 158 | GHRS | GH Research PLC | 1.02B | -2.72% | 9,570 | - |
| 159 | XNCR | Xencor, Inc. | 1.01B | -1.66% | 19,917 | 150.13M |
| 160 | VTYX | Ventyx Biosciences, Inc. | 995.17M | 0.07% | 312,719 | - |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 989.59M | -1.78% | 58,993 | 192.44M |
| 162 | ANNX | Annexon, Inc. | 976.32M | -1.95% | 282,336 | - |
| 163 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 966.66M | 0.37% | 2,546 | - |
| 164 | BCAX | Bicara Therapeutics Inc. | 952.66M | -3.50% | 8,473 | - |
| 165 | RAPT | RAPT Therapeutics, Inc. | 949.93M | -1.30% | 3,718 | - |
| 166 | VIR | Vir Biotechnology, Inc. | 923.79M | -2.64% | 188,174 | 16.86M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 919.34M | -0.89% | 20,234 | - |
| 168 | IOVA | Iovance Biotherapeutics, Inc. | 909.06M | -3.78% | 1,545,002 | 250.43M |
| 169 | ABUS | Arbutus Biopharma Corporation | 902.00M | -1.88% | 50,014 | 14.61M |
| 170 | VALN | Valneva SE | 892.29M | -2.12% | 392 | 211.09M |
| 171 | DRUG | Bright Minds Biosciences Inc. | 890.34M | -1.57% | 54 | - |
| 172 | OMER | Omeros Corporation | 875.62M | -5.58% | 489,960 | - |
| 173 | URGN | UroGen Pharma Ltd. | 869.24M | -0.91% | 19,615 | 96.52M |
| 174 | MDXG | MiMedx Group, Inc. | 853.07M | 1.23% | 34,808 | 393.44M |
| 175 | GERN | Geron Corporation | 839.44M | -2.59% | 461,659 | 183.40M |
| 176 | JANX | Janux Therapeutics, Inc. | 830.64M | -2.20% | 116,503 | 10.00M |
| 177 | YDES | YD Bio Limited | 815.71M | -1.69% | 13,750 | 510.36K |
| 178 | KURA | Kura Oncology, Inc. | 809.26M | -0.64% | 36,237 | 104.03M |
| 179 | MPLT | MapLight Therapeutics, Inc. | 800.38M | -2.24% | 32,464 | - |
| 180 | ARVN | Arvinas, Inc. | 772.62M | -1.39% | 123,415 | 312.30M |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 764.51M | -0.75% | 75,785 | 1.43M |
| 182 | RGNX | REGENXBIO Inc. | 744.67M | -1.61% | 120,736 | 161.32M |
| 183 | CTMX | CytomX Therapeutics, Inc. | 721.79M | -0.93% | 115,199 | 113.63M |
| 184 | PRME | Prime Medicine, Inc. | 720.55M | -5.57% | 558,246 | 5.98M |
| 185 | IVVD | Invivyd, Inc. | 716.25M | -2.31% | 326,032 | 50.04M |
| 186 | ATXS | Astria Therapeutics, Inc. | 713.56M | -0.32% | 24,970 | 706.00K |
| 187 | DBVT | DBV Technologies S.A. | 713.07M | 1.79% | 17,421 | 5.50M |
| 188 | NKTR | Nektar Therapeutics | 711.96M | -3.02% | 55,214 | 62.60M |
| 189 | TENX | Tenax Therapeutics, Inc. | 703.69M | -5.06% | 153,643 | - |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 697.92M | -1.71% | 25,042 | 282.08M |
| 191 | GYRE | Gyre Therapeutics, Inc. | 686.22M | -1.82% | 1,319 | 107.27M |
| 192 | JBIO | Jade Biosciences, Inc. | 685.00M | 1.57% | 7,226 | - |
| 193 | SLS | SELLAS Life Sciences Group, Inc. | 669.21M | -4.38% | 1,305,751 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 661.68M | -3.19% | 25,269 | 80.00M |
| 195 | PROK | ProKidney Corp. | 652.81M | -4.82% | 85,334 | 744.00K |
| 196 | DRTS | Alpha Tau Medical Ltd. | 650.99M | 1.80% | 122,121 | - |
| 197 | EVMN | Evommune, Inc. | 639.94M | -4.47% | 3,489 | 13.00M |
| 198 | CGEM | Cullinan Therapeutics, Inc. | 631.53M | -1.66% | 38,438 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 601.27M | 0.27% | 30,485 | 27.42M |
| 200 | ENGN | enGene Holdings Inc. | 600.18M | -1.54% | 25,741 | - |
| 201 | REPL | Replimune Group, Inc. | 600.09M | -0.78% | 121,003 | - |
| 202 | KROS | Keros Therapeutics, Inc. | 594.70M | -0.05% | 4,932 | 246.72M |
| 203 | VOR | Vor Biopharma Inc. | 584.29M | 2.17% | 164,329 | - |
| 204 | GOSS | Gossamer Bio, Inc. | 580.96M | -1.57% | 325,860 | 44.05M |
| 205 | LENZ | LENZ Therapeutics, Inc. | 579.96M | -0.30% | 200,352 | 17.50M |
| 206 | FBRX | Forte Biosciences, Inc. | 572.21M | - | 1,175 | - |
| 207 | OCGN | Ocugen, Inc. | 568.42M | -3.19% | 2,584,531 | 5.37M |
| 208 | LXEO | Lexeo Therapeutics, Inc. | 561.27M | -0.39% | 33,527 | - |
| 209 | CRMD | CorMedix Inc. | 560.98M | 0.42% | 266,373 | 214.30M |
| 210 | DSGN | Design Therapeutics, Inc. | 546.85M | -2.04% | 8,783 | - |
| 211 | DNA | Ginkgo Bioworks Holdings, Inc. | 542.22M | -3.15% | 61,245 | 180.61M |
| 212 | VSTM | Verastem, Inc. | 537.96M | 2.65% | 470,419 | 13.38M |
| 213 | ANRO | Alto Neuroscience, Inc. | 517.57M | -2.91% | 8,348 | - |
| 214 | CRVS | Corvus Pharmaceuticals, Inc. | 507.84M | -0.29% | 99,119 | - |
| 215 | ASMB | Assembly Biosciences, Inc. | 506.15M | -0.12% | 1,128 | 37.19M |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 502.74M | -3.93% | 106,540 | - |
| 217 | ZVRA | Zevra Therapeutics, Inc. | 501.61M | -2.84% | 71,010 | 84.39M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 500.40M | 0.40% | 6,353 | 41.00K |
| 219 | LBRX | LB Pharmaceuticals Inc | 492.07M | 0.46% | 5,879 | - |
| 220 | NAGE | Niagen Bioscience, Inc. | 491.75M | -2.69% | 47,823 | 124.71M |
| 221 | VTVT | vTv Therapeutics Inc. | 490.71M | -1.16% | 2,002 | 17.00K |
| 222 | PRTA | Prothena Corporation plc | 489.05M | -1.25% | 40,590 | 11.79M |
| 223 | ABSI | Absci Corporation | 485.70M | -3.58% | 588,532 | 2.82M |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 485.65M | -2.97% | 42,772 | 120.00K |
| 225 | MNPR | Monopar Therapeutics Inc. | 462.84M | -0.49% | 119,181 | - |
| 226 | BCYC | Bicycle Therapeutics plc | 460.26M | 0.23% | 7,775 | 28.34M |
| 227 | ADCT | ADC Therapeutics SA | 459.58M | - | 6,806 | 75.21M |
| 228 | LXRX | Lexicon Pharmaceuticals, Inc. | 457.88M | 1.61% | 94,936 | 70.86M |
| 229 | SLDB | Solid Biosciences Inc. | 453.44M | 0.17% | 56,441 | - |
| 230 | IMMP | Immutep Limited | 448.31M | -1.61% | 18,802 | 3.31M |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 447.38M | -2.91% | 12,371 | - |
| 232 | VNDA | Vanda Pharmaceuticals Inc. | 446.77M | -1.82% | 111,606 | 212.07M |
| 233 | ALT | Altimmune, Inc. | 443.17M | -2.87% | 303,054 | 20.00K |
| 234 | PRTC | PureTech Health plc | 438.83M | -1.05% | 45 | 6.39M |
| 235 | AVXL | Anavex Life Sciences Corp. | 433.34M | 0.62% | 96,316 | - |
| 236 | GLSI | Greenwich LifeSciences, Inc. | 429.77M | 5.91% | 110,313 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 427.10M | 3.20% | 16,564 | - |
| 238 | CTNM | Contineum Therapeutics, Inc. | 423.74M | -1.36% | 6,057 | - |
| 239 | RCKT | Rocket Pharmaceuticals, Inc. | 418.82M | -2.27% | 277,653 | - |
| 240 | NBP | NovaBridge Biosciences | 412.74M | 1.42% | 36,645 | - |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 408.32M | -0.88% | 48,994 | 10.82M |
| 242 | HELP | Cybin Inc. | 406.71M | 0.12% | 52,392 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 406.69M | -0.99% | 22,285 | - |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 400.47M | 0.25% | 23,318 | 65.32M |
| 245 | TRDA | Entrada Therapeutics, Inc. | 383.72M | 1.13% | 7,693 | 61.52M |
| 246 | AUTL | Autolus Therapeutics plc | 376.59M | -0.35% | 310,914 | 51.13M |
| 247 | ALLO | Allogene Therapeutics, Inc. | 376.42M | -1.47% | 849,603 | 22.00K |
| 248 | TECX | Tectonic Therapeutic, Inc. | 364.97M | -0.86% | 10,032 | - |
| 249 | FHTX | Foghorn Therapeutics Inc. | 356.76M | -3.49% | 8,232 | 24.52M |
| 250 | NMRA | Neumora Therapeutics, Inc. | 355.17M | -2.79% | 56,862 | - |
| 251 | ACIU | AC Immune SA | 352.73M | -2.86% | 61,214 | 5.48M |
| 252 | XOMA | XOMA Royalty Corporation | 352.67M | -3.00% | 442,036 | 47.11M |
| 253 | PEPG | PepGen Inc. | 351.99M | -0.58% | 47,192 | - |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 333.57M | 1.19% | 11,986 | 33.98M |
| 255 | ZURA | Zura Bio Limited | 329.02M | -5.77% | 33,675 | - |
| 256 | AURA | Aura Biosciences, Inc. | 327.68M | -1.90% | 5,894 | - |
| 257 | CADL | Candel Therapeutics, Inc. | 326.10M | -4.35% | 147,516 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 324.52M | 0.31% | 40,342 | 212.00M |
| 259 | AARD | Aardvark Therapeutics, Inc. | 323.77M | -0.73% | 21,978 | - |
| 260 | CAMP | Camp4 Therapeutics Corporation | 311.29M | 1.35% | 2,259 | 3.80M |
| 261 | AVTX | Avalo Therapeutics, Inc. | 301.67M | 0.65% | 8,278 | 192.00K |
| 262 | CLLS | Cellectis S.A. | 298.37M | 0.70% | 905 | 82.55M |
| 263 | IMRX | Immuneering Corporation | 297.02M | 3.84% | 343,373 | - |
| 264 | ACRS | Aclaris Therapeutics, Inc. | 296.32M | -0.18% | 43,773 | 15.74M |
| 265 | ACHV | Achieve Life Sciences, Inc. | 294.38M | -1.43% | 24,622 | - |
| 266 | STTK | Shattuck Labs, Inc. | 293.30M | -2.01% | 6,870 | 1.00M |
| 267 | LRMR | Larimar Therapeutics, Inc. | 286.73M | -1.76% | 153,240 | - |
| 268 | NGNE | Neurogene Inc. | 285.01M | -2.13% | 7,021 | 925.00K |
| 269 | RLMD | Relmada Therapeutics, Inc. | 280.13M | -0.52% | 70,237 | - |
| 270 | PALI | Palisade Bio, Inc. | 278.64M | -4.10% | 623,442 | - |
| 271 | ABEO | Abeona Therapeutics Inc. | 278.00M | -1.16% | 72,679 | 400.00K |
| 272 | SLN | Silence Therapeutics plc | 274.43M | -1.02% | 972 | 25.83M |
| 273 | OABI | OmniAb, Inc. | 274.24M | -0.26% | 10,228 | 21.09M |
| 274 | AVIR | Atea Pharmaceuticals, Inc. | 274.23M | -0.85% | 12,893 | - |
| 275 | GUTS | Fractyl Health, Inc. | 269.98M | -1.99% | 185,714 | 3.00K |
| 276 | HRTX | Heron Therapeutics, Inc. | 267.71M | -2.01% | 47,077 | 155.10M |
| 277 | TARA | Protara Therapeutics, Inc. | 266.86M | 0.81% | 185,140 | - |
| 278 | IMMX | Immix Biopharma, Inc. | 263.21M | 0.71% | 80,008 | - |
| 279 | MENS | Jyong Biotech Ltd. | 263.00M | -0.29% | 12,923 | - |
| 280 | FENC | Fennec Pharmaceuticals Inc. | 262.64M | 1.45% | 5,242 | 38.79M |
| 281 | ALDX | Aldeyra Therapeutics, Inc. | 252.68M | -0.94% | 47,090 | - |
| 282 | RZLT | Rezolute, Inc. | 250.36M | -0.74% | 465,064 | - |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 247.32M | -1.79% | 3,338 | 2.82M |
| 284 | CBIO | Crescent Biopharma, Inc. | 241.14M | -2.34% | 3,359 | - |
| 285 | NAUT | Nautilus Biotechnology, Inc. | 233.66M | -3.65% | 42,288 | - |
| 286 | ENLV | Enlivex Therapeutics Ltd. | 231.02M | 0.69% | 108,706 | - |
| 287 | VYGR | Voyager Therapeutics, Inc. | 229.63M | - | 19,978 | 31.32M |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 228.43M | -1.76% | 32,692 | 1.00 |
| 289 | MDWD | MediWound Ltd. | 221.17M | 1.23% | 4,260 | 20.93M |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 219.51M | -3.42% | 239,246 | 26.87M |
| 291 | CCCC | C4 Therapeutics, Inc. | 215.15M | -4.72% | 73,962 | 30.11M |
| 292 | ARCT | Arcturus Therapeutics Holdings Inc. | 213.68M | -2.72% | 45,639 | 97.60M |
| 293 | NVCT | Nuvectis Pharma, Inc. | 212.60M | -1.31% | 989 | - |
| 294 | HUMA | Humacyte, Inc. | 210.37M | -4.39% | 750,844 | 1.57M |
| 295 | MIST | Milestone Pharmaceuticals Inc. | 209.77M | 1.72% | 662,478 | - |
| 296 | EDIT | Editas Medicine, Inc. | 207.44M | -4.28% | 332,592 | 46.38M |
| 297 | ARMP | Armata Pharmaceuticals, Inc. | 206.43M | -0.53% | 1,824 | 5.05M |
| 298 | OVID | Ovid Therapeutics Inc. | 205.04M | -4.55% | 292,789 | 6.61M |
| 299 | CABA | Cabaletta Bio, Inc. | 203.12M | -1.86% | 159,576 | - |
| 300 | SGMT | Sagimet Biosciences Inc. | 203.10M | -1.96% | 33,380 | - |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 201.61M | -3.73% | 16,664 | 10.30M |
| 302 | ALEC | Alector, Inc. | 197.56M | -2.16% | 256,102 | 69.05M |
| 303 | CHRS | Coherus Oncology, Inc. | 194.60M | 0.63% | 72,792 | 277.73M |
| 304 | CGEN | Compugen Ltd. | 193.62M | 4.55% | 149,104 | 6.90M |
| 305 | GALT | Galectin Therapeutics Inc. | 193.42M | - | 26,823 | - |
| 306 | RNAC | Cartesian Therapeutics, Inc. | 192.95M | -2.88% | 5,475 | 1.09M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 191.77M | 1.55% | 346 | 18.97M |
| 308 | CLYM | Climb Bio, Inc. | 188.59M | -0.25% | 12,498 | - |
| 309 | SABS | SAB Biotherapeutics, Inc. | 185.43M | -2.62% | 1,016 | 114.70K |
| 310 | CRDF | Cardiff Oncology, Inc. | 184.57M | -2.49% | 66,527 | 501.00K |
| 311 | NERV | Minerva Neurosciences, Inc. | 180.89M | -3.02% | 1,276 | - |
| 312 | PRLD | Prelude Therapeutics Incorporated | 180.45M | -3.10% | 42,212 | 10.50M |
| 313 | IPSC | Century Therapeutics, Inc. | 178.99M | 1.49% | 109,361 | 113.34M |
| 314 | SRZN | Surrozen, Inc. | 175.71M | 2.50% | 394 | 3.60M |
| 315 | PRQR | ProQR Therapeutics N.V. | 174.87M | 1.22% | 46,186 | 18.86M |
| 316 | NTHI | NeOnc Technologies Holdings, Inc. | 173.32M | -4.71% | 20,295 | 59.99K |
| 317 | KLRS | Kalaris Therapeutics, Inc. | 172.06M | -0.43% | 19,662 | - |
| 318 | TLSA | Tiziana Life Sciences Ltd | 169.92M | -2.72% | 19,626 | - |
| 319 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | -1.43% | 207,588 | 1.20M |
| 320 | ELDN | Eledon Pharmaceuticals, Inc. | 164.26M | 1.97% | 30,915 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 163.25M | -1.46% | 43,151 | 61.84M |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 162.38M | -0.98% | 336,549 | - |
| 323 | IPHA | Innate Pharma S.A. | 162.21M | -0.17% | 347 | 14.84M |
| 324 | QNCX | Quince Therapeutics, Inc. | 160.36M | -4.32% | 122,483 | - |
| 325 | CDXS | Codexis, Inc. | 157.16M | -2.25% | 45,835 | 52.93M |
| 326 | MOLN | Molecular Partners AG | 155.88M | 1.19% | 514 | 856.30K |
| 327 | BDTX | Black Diamond Therapeutics, Inc. | 155.54M | -2.15% | 66,460 | 70.00M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 150.45M | -1.69% | 16,751 | - |
| 329 | CNTX | Context Therapeutics Inc. | 149.76M | 3.82% | 143,699 | - |
| 330 | IRD | Opus Genetics, Inc. | 146.89M | -1.84% | 13,926 | 14.63M |
| 331 | CRBU | Caribou Biosciences, Inc. | 146.74M | -2.48% | 247,122 | 9.30M |
| 332 | MCRB | Seres Therapeutics, Inc. | 144.74M | -0.50% | 15,133 | 351.00K |
| 333 | SGMO | Sangamo Therapeutics, Inc. | 144.52M | -0.81% | 918,507 | 32.88M |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 143.29M | -1.10% | 121,664 | 2.00M |
| 335 | NKTX | Nkarta, Inc. | 141.35M | -3.86% | 208,775 | - |
| 336 | ELTX | Elicio Therapeutics, Inc. | 140.15M | -0.12% | 1,189 | - |
| 337 | SPRO | Spero Therapeutics, Inc. | 138.59M | -1.99% | 20,240 | 40.55M |
| 338 | VXRT | Vaxart, Inc. | 136.79M | 3.83% | 191,833 | 148.20M |
| 339 | TTRX | Turn Therapeutics Inc. | 135.45M | -2.95% | 4,198 | - |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 133.89M | -5.75% | 143,278 | - |
| 341 | WHWK | Whitehawk Therapeutics, Inc. | 132.90M | -2.76% | 17,536 | 14.38M |
| 342 | ACOG | Alpha Cognition Inc. | 130.24M | 1.01% | 3,120 | 7.43M |
| 343 | KPTI | Karyopharm Therapeutics Inc. | 127.07M | -3.48% | 70,623 | 142.53M |
| 344 | VRCA | Verrica Pharmaceuticals Inc. | 125.68M | -1.13% | 3,889 | 30.83M |
| 345 | AGEN | Agenus Inc. | 124.81M | -21.58% | 1,180,150 | 106.83M |
| 346 | ACTU | Actuate Therapeutics, Inc. | 123.19M | 0.76% | 2,723 | - |
| 347 | CGTX | Cognition Therapeutics, Inc. | 123.14M | -1.76% | 107,084 | - |
| 348 | CNTB | Connect Biopharma Holdings Limited | 122.43M | 0.46% | 362 | 762.00K |
| 349 | FATE | Fate Therapeutics, Inc. | 121.12M | -2.78% | 172,600 | 7.14M |
| 350 | GNLX | Genelux Corporation | 116.03M | 0.38% | 5,703 | 8.00K |
| 351 | PYXS | Pyxis Oncology, Inc. | 114.88M | -7.29% | 210,757 | 2.82M |
| 352 | ARTV | Artiva Biotherapeutics, Inc. | 112.91M | -3.77% | 40,656 | 251.00K |
| 353 | RPTX | Repare Therapeutics Inc. | 111.65M | -0.38% | 16,966 | 11.87M |
| 354 | MGNX | MacroGenics, Inc. | 110.70M | -1.69% | 111,133 | 127.63M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 110.27M | -2.13% | 218,688 | 182.34K |
| 356 | ANIX | Anixa Biosciences, Inc. | 110.14M | -0.30% | 26,626 | - |
| 357 | THAR | Tharimmune, Inc. | 108.61M | -2.61% | 97,176 | - |
| 358 | ONCY | Oncolytics Biotech Inc. | 107.61M | -4.76% | 256,269 | - |
| 359 | BMEA | Biomea Fusion, Inc. | 106.06M | -7.41% | 621,292 | - |
| 360 | ABOS | Acumen Pharmaceuticals, Inc. | 106.00M | -2.23% | 16,587 | - |
| 361 | MREO | Mereo BioPharma Group plc | 105.60M | -7.40% | 3,443,466 | 500.00K |
| 362 | SEER | Seer, Inc. | 105.19M | -2.60% | 11,812 | 16.38M |
| 363 | CBUS | Cibus, Inc. | 104.65M | -1.03% | 12,985 | 3.79M |
| 364 | FBIO | Fortress Biotech, Inc. | 104.29M | 2.44% | 265,709 | 62.30M |
| 365 | STRO | Sutro Biopharma, Inc. | 103.94M | -3.63% | 2,878 | 105.65M |
| 366 | CSBR | Champions Oncology, Inc. | 103.45M | 3.76% | 714 | 58.42M |
| 367 | SAVA | Cassava Sciences, Inc. | 102.65M | -1.16% | 54,897 | - |
| 368 | ETHZ | ETHZilla Corporation | 102.10M | -0.74% | 76,987 | 4.11M |
| 369 | HYFT | MindWalk Holdings Corp. | 98.99M | -0.93% | 63,773 | 19.02M |
| 370 | OKYO | OKYO Pharma Limited | 95.53M | -10.25% | 53,528 | - |
| 371 | DTIL | Precision BioSciences, Inc. | 94.60M | -4.84% | 47,930 | 698.00K |
| 372 | COYA | Coya Therapeutics, Inc. | 92.90M | -4.31% | 29,166 | 3.99M |
| 373 | VANI | Vivani Medical, Inc. | 92.65M | - | 5,063 | - |
| 374 | EXOZ | eXoZymes, Inc. | 88.90M | -1.58% | - | -700.00 |
| 375 | DWTX | Dogwood Therapeutics, Inc. | 86.21M | - | 6,342 | - |
| 376 | ADAG | Adagene Inc. | 84.36M | -0.56% | 8,019 | 103.20K |
| 377 | ANVS | Annovis Bio, Inc. | 83.22M | -0.95% | 43,424 | - |
| 378 | ACET | Adicet Bio, Inc. | 83.20M | -0.70% | 31,889 | - |
| 379 | KRRO | Korro Bio, Inc. | 81.55M | -3.78% | 14,065 | 7.37M |
| 380 | GANX | Gain Therapeutics, Inc. | 81.35M | -3.86% | 208,306 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 81.19M | -3.22% | 273 | 697.00K |
| 382 | COEP | Coeptis Therapeutics Holdings, Inc. | 81.11M | 1.06% | 680 | 501.00K |
| 383 | PLRX | Pliant Therapeutics, Inc. | 80.50M | - | 164,315 | - |
| 384 | IMUX | Immunic, Inc. | 79.52M | 1.71% | 282,296 | - |
| 385 | CALC | CalciMedica, Inc. | 78.68M | -0.18% | 3,627 | - |
| 386 | ATOS | Atossa Therapeutics, Inc. | 78.26M | 0.65% | 136,526 | - |
| 387 | XBIT | XBiotech Inc. | 77.44M | -2.68% | 11,900 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 76.40M | -1.39% | 1,950 | 7.41M |
| 389 | ENTX | Entera Bio Ltd. | 75.66M | 1.23% | 888 | 124.00K |
| 390 | KZIA | Kazia Therapeutics Limited | 75.51M | 1.32% | 3,664 | 1.20M |
| 391 | MNOV | MediciNova, Inc. | 75.19M | 6.25% | 54,243 | 257.92K |
| 392 | IMA | ImageneBio, Inc. | 72.43M | -0.44% | 319 | 800.00K |
| 393 | ALXO | ALX Oncology Holdings Inc. | 71.57M | -0.75% | 7,833 | - |
| 394 | IFRX | InflaRx N.V. | 70.46M | -2.80% | 30,799 | 73.73K |
| 395 | PYPD | PolyPid Ltd. | 70.37M | -2.53% | 3,630 | - |
| 396 | EQ | Equillium, Inc. | 69.42M | -0.87% | 47,720 | 4.39M |
| 397 | ATYR | aTyr Pharma, Inc. | 68.27M | -2.95% | 45,386 | 190.00K |
| 398 | BYSI | BeyondSpring Inc. | 66.62M | -2.99% | 4,641 | 1.88M |
| 399 | TCRX | TScan Therapeutics, Inc. | 64.69M | -5.00% | 36,043 | 8.42M |
| 400 | CRVO | CervoMed Inc. | 64.58M | -0.14% | 3,176 | 6.16M |
| 401 | TVGN | Tevogen Bio Holdings Inc. | 64.26M | 1.73% | 66,347 | - |
| 402 | LPCN | Lipocine Inc. | 63.29M | 3.64% | 22,818 | 4.32M |
| 403 | MGX | Metagenomi Therapeutics, Inc. | 63.08M | -2.89% | 18,664 | 30.91M |
| 404 | ANL | Adlai Nortye Ltd. | 62.36M | 4.97% | 8,669 | -1.35M |
| 405 | NRXP | NRx Pharmaceuticals, Inc. | 62.32M | -2.09% | 312,700 | 242.00K |
| 406 | ATHE | Alterity Therapeutics Limited | 61.80M | 0.84% | 166 | 3.57M |
| 407 | RADX | Radiopharm Theranostics Limited | 61.61M | 0.19% | 13,434 | 8.20M |
| 408 | MAIA | MAIA Biotechnology, Inc. | 61.23M | -3.03% | 40,122 | - |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 60.40M | -0.44% | 54,787 | - |
| 410 | ICCC | ImmuCell Corporation | 59.88M | - | - | 27.77M |
| 411 | ACRV | Acrivon Therapeutics, Inc. | 57.11M | -1.09% | 137,357 | - |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.79M | 0.83% | 13,451 | - |
| 413 | ALGS | Aligos Therapeutics, Inc. | 56.72M | 1.85% | 8,199 | 2.65M |
| 414 | INKT | MiNK Therapeutics, Inc. | 54.57M | -0.81% | 2,898 | - |
| 415 | OSTX | OS Therapies Incorporated | 53.53M | -1.94% | 721,263 | - |
| 416 | IBIO | iBio, Inc. | 53.52M | -4.42% | 148,783 | 500.00K |
| 417 | LITS | Lite Strategy, Inc. | 53.32M | -6.45% | 67,911 | - |
| 418 | PDSB | PDS Biotechnology Corporation | 53.15M | -1.43% | 112,624 | - |
| 419 | NTRB | Nutriband Inc. | 52.45M | 1.53% | 320 | 2.28M |
| 420 | NRXS | NeurAxis, Inc. | 50.39M | -0.21% | 1,191 | 3.36M |
| 421 | IBO | Impact BioMedical Inc. | 49.75M | -1.76% | 2,113 | 25.00K |
| 422 | PASG | Passage Bio, Inc. | 49.37M | 2.44% | 1,994 | - |
| 423 | ABVC | ABVC BioPharma, Inc. | 48.79M | -0.48% | 6,282 | 797.92K |
| 424 | TIL | Instil Bio, Inc. | 48.15M | -1.25% | 15,262 | - |
| 425 | NXTC | NextCure, Inc. | 47.75M | 5.09% | 7,338 | - |
| 426 | PTN | Palatin Technologies, Inc. | 47.18M | 1.19% | 6,556 | 8.85M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 46.41M | - | 18,947 | - |
| 428 | HURA | TuHURA Biosciences, Inc. | 45.88M | -0.16% | 43,641 | - |
| 429 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.19M | -0.90% | 4,287 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.18M | - | 266 | - |
| 431 | CVM | CEL-SCI Corporation | 44.31M | - | 22,256 | - |
| 432 | OKUR | OnKure Therapeutics, Inc. | 43.90M | 1.57% | 4,148 | - |
| 433 | QTTB | Q32 Bio Inc. | 43.80M | -1.11% | 11,710 | - |
| 434 | XLO | Xilio Therapeutics, Inc. | 43.56M | -0.12% | 27,416 | 31.80M |
| 435 | JSPR | Jasper Therapeutics, Inc. | 43.10M | -4.94% | 96,261 | - |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 42.59M | -1.94% | 7,977 | - |
| 437 | APLM | Apollomics, Inc. | 42.56M | 0.05% | 497 | 6.93M |
| 438 | ESLA | Estrella Immunopharma, Inc. | 42.45M | -2.88% | 4,143 | - |
| 439 | EVAX | Evaxion A/S | 42.03M | -0.40% | 6,469 | 7.65M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 40.87M | -1.50% | 7,583 | 90.00K |
| 441 | INMB | INmune Bio, Inc. | 40.68M | -0.65% | 59,878 | 50.00K |
| 442 | XCUR | Exicure, Inc. | 40.07M | 4.79% | 40,577 | 500.00K |
| 443 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.72M | -2.89% | 436,688 | - |
| 444 | LTRN | Lantern Pharma Inc. | 39.59M | - | 3,384 | - |
| 445 | CELU | Celularity Inc. | 38.93M | 1.50% | 803 | 40.58M |
| 446 | RNXT | RenovoRx, Inc. | 38.48M | -0.94% | 6,361 | 928.00K |
| 447 | GLTO | Galecto, Inc. | 38.28M | -3.96% | 2,090 | - |
| 448 | PSTV | Plus Therapeutics, Inc. | 38.11M | -4.51% | 5,821,495 | 5.26M |
| 449 | GBIO | Generation Bio Co. | 37.79M | -0.88% | 4,822 | 15.27M |
| 450 | IOBT | IO Biotech, Inc. | 37.41M | -2.99% | 33,984 | - |
| 451 | VERU | Veru Inc. | 37.08M | -1.28% | 9,358 | 16.89M |
| 452 | ANTX | AN2 Therapeutics, Inc. | 35.90M | - | 890 | - |
| 453 | CING | Cingulate Inc. | 35.20M | -1.21% | 6,653 | - |
| 454 | ATRA | Atara Biotherapeutics, Inc. | 33.82M | 4.92% | 188,712 | 151.93M |
| 455 | OTLK | Outlook Therapeutics, Inc. | 32.95M | -4.83% | 659,572 | 1.41M |
| 456 | GNTA | Genenta Science S.p.A. | 32.10M | - | 2,882 | - |
| 457 | SKYE | Skye Bioscience, Inc. | 31.48M | -3.73% | 40,895 | - |
| 458 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.10M | -0.14% | 4,244 | - |
| 459 | DYAI | Dyadic International, Inc. | 30.76M | -3.37% | 10,320 | 3.34M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 30.62M | -0.64% | 226 | 14.97M |
| 461 | MRKR | Marker Therapeutics, Inc. | 30.09M | -0.82% | 66,257 | 4.69M |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 29.76M | -6.36% | 133,286 | - |
| 463 | RLYB | Rallybio Corporation | 29.57M | 2.15% | 4,646 | 674.00K |
| 464 | PLUR | Pluri Inc. | 29.57M | 4.40% | 402 | 1.33M |
| 465 | RNTX | Rein Therapeutics Inc. | 28.92M | -1.79% | 3,989 | - |
| 466 | SER | Serina Therapeutics, Inc. | 28.79M | 1.12% | 2,180 | 116.00K |
| 467 | HYPD | Hyperion DeFi, Inc. | 28.64M | -3.94% | 22,983 | 345.32K |
| 468 | DARE | Daré Bioscience, Inc. | 28.58M | -1.48% | 4,371 | -57.13K |
| 469 | IGC | IGC Pharma, Inc. | 28.06M | -2.30% | 70,974 | 1.11M |
| 470 | QNTM | Quantum BioPharma Ltd. | 27.64M | -1.78% | 14,232 | - |
| 471 | SNTI | Senti Biosciences, Inc. | 27.61M | -4.55% | 55,715 | - |
| 472 | JUNS | Jupiter Neurosciences, Inc. | 27.54M | -1.25% | 13,893 | - |
| 473 | BOLD | Boundless Bio, Inc. | 27.42M | -2.77% | 16,334 | - |
| 474 | HOWL | Werewolf Therapeutics, Inc. | 27.21M | -4.06% | 51,899 | 1.14M |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 27.02M | -2.47% | 209,131 | 721.00K |
| 476 | CUE | Cue Biopharma, Inc. | 26.72M | -14.11% | 289,065 | 7.10M |
| 477 | LONA | LeonaBio, Inc. | 25.99M | 0.15% | 773 | - |
| 478 | INTS | Intensity Therapeutics, Inc. | 25.14M | -1.53% | 86,729 | - |
| 479 | NNVC | NanoViricides, Inc. | 24.85M | 0.18% | 9,313 | - |
| 480 | PLRZ | Polyrizon Ltd. | 22.92M | -4.77% | 10,474 | - |
| 481 | FBLG | FibroBiologics, Inc. | 22.63M | - | 95,924 | - |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 21.83M | 0.50% | 2,192 | 15.65M |
| 483 | CLGN | CollPlant Biotechnologies Ltd. | 21.66M | 1.50% | 339 | 2.48M |
| 484 | KLTO | Klotho Neurosciences, Inc. | 21.47M | -3.31% | 111,046 | - |
| 485 | LNAI | Lunai Bioworks Inc. | 21.35M | -5.28% | 90,403 | - |
| 486 | LIMN | Liminatus Pharma, Inc. | 21.16M | 4.25% | 24,483 | - |
| 487 | ALLR | Allarity Therapeutics, Inc. | 20.84M | -0.83% | 20,181 | - |
| 488 | CASI | CASI Pharmaceuticals, Inc. | 19.98M | -4.69% | 218,345 | 26.85M |
| 489 | KTTA | Pasithea Therapeutics Corp. | 19.86M | -2.25% | 16,826 | - |
| 490 | LSTA | Lisata Therapeutics, Inc. | 19.41M | 5.77% | 10,997 | 1.07M |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 19.36M | -1.43% | 876 | - |
| 492 | BCAB | BioAtla, Inc. | 19.34M | -3.36% | 445,206 | 11.00M |
| 493 | LEXX | Lexaria Bioscience Corp. | 19.23M | -1.21% | 4,738 | 522.00K |
| 494 | VYNE | VYNE Therapeutics Inc. | 18.75M | -0.56% | 42,294 | 524.00K |
| 495 | KALA | KALA BIO, Inc. | 18.14M | 1.52% | 74,839 | - |
| 496 | OSRH | OSR Holdings, Inc. | 17.76M | -5.76% | 350,007 | -90.52K |
| 497 | PMN | ProMIS Neurosciences, Inc. | 17.75M | 1.29% | 179 | - |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 17.52M | -2.23% | 2,146 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 17.51M | -2.22% | 31,448 | - |
| 500 | ITRM | Iterum Therapeutics plc | 17.04M | -1.07% | 10,032 | 390.00K |
| 501 | HOTH | Hoth Therapeutics, Inc. | 16.45M | 1.44% | 2,188,084 | - |
| 502 | COCP | Cocrystal Pharma, Inc. | 15.99M | - | 14,306 | - |
| 503 | CLRB | Cellectar Biosciences, Inc. | 15.52M | -2.27% | 25,906 | - |
| 504 | BCDA | BioCardia, Inc. | 15.18M | 0.70% | 6,856 | 3.00K |
| 505 | APLT | Applied Therapeutics, Inc. | 15.15M | -0.50% | 63,110,557 | 1.00M |
| 506 | SNSE | Sensei Biotherapeutics, Inc. | 14.64M | -3.14% | 2,289 | - |
| 507 | NCNA | NuCana plc | 13.86M | - | 15,394 | - |
| 508 | SNGX | Soligenix, Inc. | 13.52M | -2.90% | 50,073 | 2.34K |
| 509 | TRAW | Traws Pharma, Inc. | 13.26M | -6.21% | 63,353 | 2.85M |
| 510 | SYBX | Synlogic, Inc. | 13.22M | - | - | 8.00K |
| 511 | AEON | AEON Biopharma, Inc. | 13.14M | 0.23% | 2,550 | - |
| 512 | GRDX | GridAI Technologies Corp. | 13.06M | 0.39% | 569 | - |
| 513 | AKTX | Akari Therapeutics, Plc | 12.82M | 4.67% | 10,087 | - |
| 514 | BOLT | Bolt Biotherapeutics, Inc. | 12.73M | 2.85% | 5,831 | 5.20M |
| 515 | MBRX | Moleculin Biotech, Inc. | 12.69M | -0.48% | 6,372 | - |
| 516 | BLRX | BioLineRx Ltd. | 12.41M | -0.35% | 275 | 12.74M |
| 517 | IMNN | Imunon, Inc. | 12.24M | -1.37% | 8,280 | - |
| 518 | EDSA | Edesa Biotech, Inc. | 12.17M | 0.69% | 718 | - |
| 519 | LGVN | Longeveron Inc. | 12.12M | 1.87% | 4,840 | 1.44M |
| 520 | TPST | Tempest Therapeutics, Inc. | 11.87M | -5.49% | 29,303 | - |
| 521 | PHIO | Phio Pharmaceuticals Corp. | 11.79M | -2.20% | 40,302 | - |
| 522 | CRIS | Curis, Inc. | 11.79M | 0.81% | 62,416 | 11.65M |
| 523 | CMMB | Chemomab Therapeutics Ltd. | 11.05M | 1.41% | 2,883 | - |
| 524 | NCEL | NewcelX Ltd. | 10.94M | -2.44% | 3,676 | - |
| 525 | GDTC | CytoMed Therapeutics Limited | 10.79M | - | 5,579 | 573.19K |
| 526 | ABP | Abpro Holdings, Inc. | 10.32M | -2.44% | 7,920 | 183.00K |
| 527 | BRTX | BioRestorative Therapies, Inc. | 10.30M | -1.70% | 92 | 383.40K |
| 528 | INAB | IN8bio, Inc. | 10.15M | -0.90% | 4,882 | - |
| 529 | ERNA | Ernexa Therapeutics Inc. | 10.05M | 0.79% | 1,826 | 1,000.00 |
| 530 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.61M | 1.69% | 954 | - |
| 531 | EVGN | Evogene Ltd. | 9.46M | 1.90% | 4,371 | 8.02M |
| 532 | ICU | SeaStar Medical Holding Corporation | 9.26M | -7.89% | 38,974 | 881.00K |
| 533 | BIVI | BioVie Inc. | 9.16M | 0.41% | 3,416 | - |
| 534 | BCTX | BriaCell Therapeutics Corp. | 9.15M | -2.26% | 284,590 | - |
| 535 | PMCB | PharmaCyte Biotech, Inc. | 9.12M | -1.61% | 11,454 | - |
| 536 | ALZN | Alzamend Neuro, Inc. | 8.90M | 3.08% | 465 | - |
| 537 | PULM | Pulmatrix, Inc. | 8.77M | 1.27% | 1,777 | 3.00K |
| 538 | APVO | Aptevo Therapeutics Inc. | 8.75M | -2.61% | 5,862 | - |
| 539 | IMRN | Immuron Limited | 8.49M | 1.94% | 20,026 | 4.78M |
| 540 | APM | Aptorum Group Limited | 8.47M | -1.89% | 14,417 | - |
| 541 | ADXN | Addex Therapeutics Ltd | 8.23M | -0.12% | 184 | 198.82K |
| 542 | CLDI | Calidi Biotherapeutics, Inc. | 8.15M | -0.51% | 2,480 | - |
| 543 | RNAZ | TransCode Therapeutics, Inc. | 8.15M | -1.50% | 489 | - |
| 544 | KPRX | Kiora Pharmaceuticals, Inc. | 8.14M | - | - | 20.00K |
| 545 | XTLB | XTL Biopharmaceuticals Ltd. | 8.10M | -4.07% | 62,891 | 968.00K |
| 546 | PCSA | Processa Pharmaceuticals, Inc. | 7.82M | -0.29% | 6,927 | - |
| 547 | MBIO | Mustang Bio, Inc. | 7.81M | -0.93% | 10,131 | - |
| 548 | GTBP | GT Biopharma, Inc. | 7.60M | 8.27% | 5,898,222 | - |
| 549 | TOVX | Theriva Biologics, Inc. | 7.10M | -0.82% | 323,537 | - |
| 550 | PPBT | Purple Biotech Ltd | 7.07M | -3.02% | 13,170 | - |
| 551 | BGMS | Bio Green Med Solution, Inc. | 7.06M | 0.70% | 9,151 | 81.00K |
| 552 | MTVA | MetaVia Inc. | 7.02M | -41.14% | 738,590 | - |
| 553 | GNPX | Genprex, Inc. | 6.96M | 4.53% | 611,232 | - |
| 554 | SLXN | Silexion Therapeutics Corp | 6.88M | 3.77% | 6,473 | - |
| 555 | DCOY | Decoy Therapeutics Inc. | 6.51M | 17.24% | 213,274 | - |
| 556 | APRE | Aprea Therapeutics, Inc. | 6.36M | 1.11% | 272 | 488.24K |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 6.29M | -2.19% | 5,495 | - |
| 558 | CELZ | Creative Medical Technology Holdings, Inc. | 6.29M | -2.70% | 653 | 6.00K |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 6.14M | -0.94% | 57,209 | - |
| 560 | TCRT | Alaunos Therapeutics, Inc. | 6.12M | - | 409 | 6.00K |
| 561 | ASBP | Aspire Biopharma Holdings, Inc. | 5.70M | -9.71% | 6,506,573 | 1.94K |
| 562 | PPCB | Propanc Biopharma, Inc. | 5.61M | -0.92% | 40,167 | - |
| 563 | CANF | Can-Fite BioPharma Ltd. | 5.61M | 0.70% | 7,930 | 560.00K |
| 564 | CYCN | Cyclerion Therapeutics, Inc. | 5.48M | -5.26% | 45,048 | 2.86M |
| 565 | REVB | Revelation Biosciences, Inc. | 5.33M | -0.03% | 6,664 | - |
| 566 | SILO | Silo Pharma, Inc. | 5.31M | 1.85% | 41,625 | 72.10K |
| 567 | INDP | Indaptus Therapeutics, Inc. | 5.27M | -2.59% | 16,502 | - |
| 568 | XBIO | Xenetic Biosciences, Inc. | 5.19M | 2.60% | 891 | 2.86M |
| 569 | VIVS | VivoSim Labs, Inc. | 5.16M | -1.49% | 5,052 | 140.00K |
| 570 | CNSP | CNS Pharmaceuticals, Inc. | 5.02M | 30.65% | 401,707 | - |
| 571 | GOVX | GeoVax Labs, Inc. | 4.67M | -4.90% | 35,543 | 3.35M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.55M | - | 926 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.45M | -1.25% | 1,817 | - |
| 574 | ENVB | Enveric Biosciences, Inc. | 4.09M | -3.61% | 2,421 | - |
| 575 | XRTX | XORTX Therapeutics Inc. | 4.06M | 3.09% | 15,082 | - |
| 576 | PHGE | BiomX Inc. | 3.94M | -2.27% | 5,017 | - |
| 577 | OGEN | Oragenics, Inc. | 3.88M | 1.09% | 705 | - |
| 578 | CMND | Clearmind Medicine Inc. | 3.69M | 0.41% | 30,997 | - |
| 579 | LYRA | Lyra Therapeutics, Inc. | 3.48M | 3.70% | 1,534 | 600.00K |
| 580 | GRI | GRI Bio, Inc. | 3.29M | -0.80% | 398,502 | - |
| 581 | ENSC | Ensysce Biosciences, Inc. | 3.28M | -3.01% | 3,580 | 4.49M |
| 582 | ARTL | Artelo Biosciences, Inc. | 3.27M | 0.62% | 10,968 | - |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.27M | -1.65% | 14,076 | 15.78K |
| 584 | JAGX | Jaguar Health, Inc. | 3.27M | -5.80% | 77,400 | 11.79M |
| 585 | SPRC | SciSparc Ltd. | 3.24M | -8.33% | 176,387 | 1.31M |
| 586 | SCNI | Scinai Immunotherapeutics Ltd. | 3.19M | -4.10% | 10,953 | 1.15M |
| 587 | HCWB | HCW Biologics Inc. | 3.16M | 1.74% | 1,454 | 422.03K |
| 588 | BBLG | Bone Biologics Corporation | 2.94M | 1.86% | 1,379 | - |
| 589 | AZTR | Azitra, Inc. | 2.90M | -2.17% | 1,171,653 | 7.50K |
| 590 | DRMA | Dermata Therapeutics, Inc. | 2.70M | 4.55% | 70,159 | - |
| 591 | VRAX | Virax Biolabs Group Limited | 2.42M | -2.28% | 10,338 | 2.99K |
| 592 | ONCO | Onconetix, Inc. | 2.35M | -5.03% | 3,364 | 1.22M |
| 593 | CDT | CDT Equity Inc. | 2.35M | -3.57% | 3,347 | - |
| 594 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 1.95M | -3.56% | 584,519 | 1.36M |
| 595 | BDRX | Biodexa Pharmaceuticals Plc | 1.77M | 0.96% | 39,610 | 104.90K |
| 596 | ADTX | Aditxt, Inc. | 1.28M | -1.53% | 25,713 | 5.95K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.25M | -14.49% | 219,293 | - |
| 598 | MLEC | Moolec Science SA | 954.65K | 1.09% | 2,011 | 7.83M |
| 599 | ELAB | PMGC Holdings Inc. | 678.08K | 2.39% | 32,150 | 285.95K |